Brokerages Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) Price Target at $95.09

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been given an average rating of “Moderate Buy” by the eleven ratings firms that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $95.09.

GEHC has been the subject of a number of recent research reports. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their price objective for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Morgan Stanley increased their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research note on Monday, February 12th. Citigroup lifted their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. HSBC initiated coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 target price for the company. Finally, Evercore ISI lifted their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of GEHC. Wynn Capital LLC raised its stake in shares of GE HealthCare Technologies by 4.1% during the 1st quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock worth $284,000 after buying an additional 122 shares during the period. Byrne Asset Management LLC raised its stake in shares of GE HealthCare Technologies by 0.8% during the 1st quarter. Byrne Asset Management LLC now owns 16,424 shares of the company’s stock worth $1,493,000 after buying an additional 126 shares during the period. WASHINGTON TRUST Co increased its position in shares of GE HealthCare Technologies by 7.7% during the first quarter. WASHINGTON TRUST Co now owns 1,853 shares of the company’s stock worth $168,000 after purchasing an additional 133 shares in the last quarter. Fiduciary Trust Co increased its position in shares of GE HealthCare Technologies by 1.8% during the fourth quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock worth $595,000 after purchasing an additional 133 shares in the last quarter. Finally, Janney Capital Management LLC increased its position in shares of GE HealthCare Technologies by 4.7% during the fourth quarter. Janney Capital Management LLC now owns 3,289 shares of the company’s stock worth $254,000 after purchasing an additional 149 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $76.24 on Friday. GE HealthCare Technologies has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The business has a 50-day simple moving average of $88.98 and a two-hundred day simple moving average of $78.75. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The firm has a market cap of $34.79 billion, a price-to-earnings ratio of 25.25, a price-to-earnings-growth ratio of 3.00 and a beta of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same quarter in the prior year, the firm earned $1.31 EPS. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. On average, analysts expect that GE HealthCare Technologies will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is presently 3.97%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.